看多

CWBR antiaging stock Price Target

I think antiaging stocks will be the new FAANGS in 5 to 10 years.
Immortality here, on earth, is the next frontier for the medicine.

CohBar is developing mitochondria-based therapeutics for the treatment of chronic and age-related diseases.

On 11/12/2021 Cantor Fitzgerald brokerage Initiated Coverage on CWBR with an Overweight rating and a price target of $2.50.

This all time low looks like a great buy opportunity for me.

Looking forward to read your opinion on it.

anti-agingantiagingbuycohbarCWBRcwbrstockFundamental AnalysisTechnical IndicatorsmitochondriapricetargetsignalTrend Analysis

更多:

免責聲明